Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment

AIDS

Volumn 14, Issue 11, 2000, Pages 1656-1658

  Morsica, G ^a   De Bona, A ^a   Foppa, C U ^a   Sitia, G ^a   Finazzi, R ^a   Lazzarin, A ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; LAMIVUDINE; RIBAVIRIN; STAVUDINE; ZIDOVUDINE;

ABDOMINAL PAIN; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; INCIDENCE; LIVER CIRRHOSIS; LYMPHOCYTE COUNT; MALE; NAUSEA; PRIORITY JOURNAL; VIREMIA; VIRUS LOAD; VOMITING;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C, CHRONIC; HIV SEROPOSITIVITY; HIV-1; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; RIBAVIRIN; RNA, VIRAL; VIRAL LOAD;

EID: 0033811133     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200007280-00023     Document Type: Article

References (15)

1. Hepatitis C
2. HIV infection modifies the natural history of chronic parenterally acquired hepatitis C with an unusually rapid progression to cirrhosis. A multicenter study on 547 patients
3. Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group
4. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections
5. Rapid decline of CD4+ cells after IFNα treatment in HIV-1 infection
6. CD4+ T-lymphocytopenia in HIV-infected patients receiving interferon therapy for chronic hepatitis C
7. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
8. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
9. A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy
10. Multicenter clinical trial of oral ribavirin in symptomatic HIV-infected patients
11. Hepatitis C virus six years on
12. Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro
13. Effect of ribavirin on zidovudine efficacy and toxicity in vitro: A concentration-dependent interaction
14. Antiretroviral therapy in adults. Updated recommendations of the International AIDS Society - USA panel
15. Management of chronic hepatitis C in HIV-infected patients